JPY2,670.00
0.45% today
Tokyo, Feb 28, 07:15 am CET
ISIN
JP3546800008
Symbol
4543
Index
Sector

Terumo Stock price

JPY2,663.00
-378.00 12.43% 1M
-100.00 3.62% 6M
-399.00 13.03% YTD
-257.00 8.80% 1Y
+808.50 43.60% 3Y
+924.00 53.13% 5Y
+1,839.25 223.28% 10Y
Tokyo, Closing price Fri, Feb 28 2025
-19.00 0.71%
ISIN
JP3546800008
Symbol
4543
Index
Sector

Key metrics

Market capitalization JPY3.93t
Enterprise Value JPY3.91t
P/E (TTM) P/E ratio 31.79
EV/FCF (TTM) EV/FCF 28.68
EV/Sales (TTM) EV/Sales 3.86
P/S ratio (TTM) P/S ratio 3.89
P/B ratio (TTM) P/B ratio 2.82
Dividend yield 0.97%
Last dividend (FY25) JPY26.00
Revenue growth (TTM) Revenue growth 14.23%
Revenue (TTM) Revenue JPY1.01t
EBIT (operating result TTM) EBIT JPY171.72b
Free Cash Flow (TTM) Free Cash Flow JPY136.18b
Cash position JPY212.56b
EPS (TTM) EPS JPY84.36
P/E forward 30.95
P/S forward 3.84
EV/Sales forward 3.82
Show more

Is Terumo a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Terumo Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Terumo forecast:

9x Buy
69%
4x Hold
31%

Analyst Opinions

13 Analysts have issued a Terumo forecast:

Buy
69%
Hold
31%

Financial data from Terumo

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,011,147 1,011,147
14% 14%
100%
- Direct Costs 464,673 464,673
8% 8%
46%
546,474 546,474
20% 20%
54%
- Selling and Administrative Expenses 290,168 290,168
54% 54%
29%
- Research and Development Expense - -
-
-
256,306 256,306
28% 28%
25%
- Depreciation and Amortization 84,585 84,585
14% 14%
8%
EBIT (Operating Income) EBIT 171,721 171,721
35% 35%
17%
Net Profit 125,099 125,099
26% 26%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Terumo directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan

Head office Japan
CEO Hikaru Samejima
Employees 30,591
Founded 1921
Website www.terumo.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today